Deeper dives on the questions we get asked most: comparing GLP-1s, real Canadian pricing, how telehealth prescribing actually works, and the honest truth about "research-use-only" peptides.
Same class, different molecules, different average results, different Canadian access. A plain-language head-to-head on efficacy, side effects, cost, and coverage for Canadian patients considering Ozempic/Wegovy vs Mounjaro/Zepbound.
Read the comparison →Real pharmacy prices, real SK Drug Plan behaviour, real private-benefit patterns. A ground-truth breakdown of what a Saskatchewan resident actually pays for Ozempic — from Regina to Moose Jaw to rural SK.
Read the cost breakdown →How does a company like Felix or Maple actually prescribe you a GLP-1 without you seeing a doctor in person? Who's the prescriber, who's the pharmacy, and what regulatory framework holds it all together?
Read the explainer →Why "not for human consumption" vials aren't a legal loophole, what Health Canada has actually said about the peptide gray market, and what the honest Canadian alternatives look like.
Read the safety piece →The two-minute eligibility quiz narrows six Canadian clinics down to the ones that fit your province, goal, and budget.
Editorial + affiliate disclosure: Flatland Health is an independent Canadian publisher. Some links to telehealth providers are affiliate links — if you sign up, we may earn a commission at no extra cost to you. We only recommend clinics that prescribe Health Canada-authorized medications. Content is for education only and is not medical advice. Read the full disclosure →
